Aetiopathology of rheumatoid arthritis

Medicine (United Kingdom)

Volumn 42, Issue 5, 2014, Pages 227-230

  Taylor, Peter C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Aetiopathogenesis; angiogenesis; anti citrullinated peptide antibodies; B cell; co stimulation; cytokine; dendritic cells; rheumatoid arthritis; T cell

Indexed keywords

AUTOANTIBODY; CYTOKINE;

ARTICLE; CELLULAR SECRETION; CYTOKINE RELEASE; CYTOPATHOLOGY; ENVIRONMENTAL FACTOR; GENE INTERACTION; HEREDITY; HUMAN; IMMUNE DYSREGULATION; MEDIATOR RELEASE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

EID: 84900437795     PISSN: 13573039     EISSN: 13654357     Source Type: Journal    
DOI: 10.1016/j.mpmed.2014.02.010     Document Type: Review

References (21)

1. P.C. Taylor Rheumatoid arthritis in practice 2006 Royal Society of Medicine Press London
2. P.K. Gregersen, J. Silver, and R.J. Winchester The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis Arthritis Rheum 30 1987 1205 1213
3. R.J. Winchester, and P.K. Gregersen The molecular basis of susceptibility to rheumatoid arthritis: the conformational equivalence hypothesis Springer Semin Immunopathol 10 1988 119 139
4. J. Hammer, F. Gallazzi, and E. Bono et al. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association J Exp Med 181 1995 1847 1855
5. S.F. Nielsen, S.E. Bojesen, P. Schnohr, and B.G. Nordestgaard Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study BMJ 345 2012 e5244
6. L. Padyukov, C. Silva, P. Stolt, L. Alfredsson, and L. Klareskog A gene environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis Arthritis Rheum 50 2004 3085 3092
7. L. Klareskog, P. Stolt, and K. Lundberg et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)- restricted immune reactions to autoantigens modified by citrullination Arthritis Rheum 54 2006 38 46
8. M.M. Nielen, A.R. van der Horst, and D. van Schaardenburg et al. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis Ann Rheum Dis 64 2005 1199 1204
9. B. Vander Cruyssen, T. Cantaert, and L. Nogueira et al. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays Arthritis Res Ther 8 2006 R122
10. C. Dejaco, W. Klotz, H. Larcher, C. Duftner, M. Schirmer, and M. Herold Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis Arthritis Res Ther 8 2006 R119
11. H. Bang, K. Egerer, and A. Gauliard et al. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis Arthritis Rheum 56 2007 2503 2511
12. M.K. Koivula, M. Heliövaara, and J. Ramberg et al. Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis Ann Rheum Dis 66 2007 1450 1455
13. O. Snir, M. Widhe, and C. von Spee et al. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles Ann Rheum Dis 68 2009 May 736 743
14. D. Aletaha, T. Neogi, and A.J. Silman et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Arthritis Rheum 62 2010 2569 2581
15. W. Taylor Rheumatoid arthritis S. Offermanns, W. Rosenthal, Encyclopedia of Molecular Pharmacology vol. 2 2nd edn. 2008 Springer New York 1080 1085
16. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
17. Y.Y. Kong, U. Feige, and I. Sarosi et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature 402 1999 304 309
18. P.C. Taylor Antibody therapy for rheumatoid arthritis Curr Opin Pharmacol 3 2003 323 328
19. P.C. Taylor Cell-targeted biologics and targets: rituximab, abatacept, and other biologics. Ch 64 Gary S. Firestein, Ralph C. Budd, Sherine E. Gabriel, James R. O'Dell, Iain B. McInnes, Kelley's Textbook of Rheumatology 9th edn. 2013 Saunders Elsevier Philadelphia 978 1000 ISBN: 978-1-4377-1738-9
20. P.C. Taylor Tumour necrosis factor blocking therapies 6th edn. M.C. Hochberg, A.J. Silman, J.S. Smolen, M.E. Weinblatt, M.H. Weisman, In Rheumatology Volume 1 2014 Mosby Elsevier
21. J.J. O'Shea, A. Kontzias, K. Yamaoka, Y. Tanaka, and A. Laurence Ann Rheum Dis 72 2013 ii111 ii115